These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17074809)

  • 1. TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.
    Zhong S; Fromm J; Johnson DL
    Mol Cell Biol; 2007 Jan; 27(1):54-64. PubMed ID: 17074809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The JNKs differentially regulate RNA polymerase III transcription by coordinately modulating the expression of all TFIIIB subunits.
    Zhong S; Johnson DL
    Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12682-7. PubMed ID: 19620725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
    Liu J; Minemoto Y; Lin A
    Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.
    Sabapathy K; Hochedlinger K; Nam SY; Bauer A; Karin M; Wagner EF
    Mol Cell; 2004 Sep; 15(5):713-25. PubMed ID: 15350216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JNK2: a negative regulator of cellular proliferation.
    Sabapathy K; Wagner EF
    Cell Cycle; 2004 Dec; 3(12):1520-3. PubMed ID: 15611655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor 1 (EGFR1) and its variant EGFRvIII regulate TATA-binding protein expression through distinct pathways.
    Fromm JA; Johnson SA; Johnson DL
    Mol Cell Biol; 2008 Oct; 28(20):6483-95. PubMed ID: 18710943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of stress kinase JNK2 in pro-arrhythmic CaMKIIδ expression in the aged atrium.
    Gao X; Wu X; Yan J; Zhang J; Zhao W; DeMarco D; Zhang Y; Bakhos M; Mignery G; Sun J; Li Z; Fill M; Ai X
    Cardiovasc Res; 2018 Apr; 114(5):737-746. PubMed ID: 29360953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18.
    Yeap YY; Ng IH; Badrian B; Nguyen TV; Yip YY; Dhillon AS; Mutsaers SE; Silke J; Bogoyevitch MA; Ng DC
    Biochem J; 2010 Sep; 430(2):345-54. PubMed ID: 20594188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
    Oleinik NV; Krupenko NI; Krupenko SA
    Oncogene; 2007 Nov; 26(51):7222-30. PubMed ID: 17525747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis.
    Hochedlinger K; Wagner EF; Sabapathy K
    Oncogene; 2002 Apr; 21(15):2441-5. PubMed ID: 11948429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
    Tan J; Gao W; Yang W; Zeng X; Wang L; Cui X
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):e143-e156. PubMed ID: 32414595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of c-Jun N-terminal kinase isoforms in the cellular activity of melanoma cell lines.
    Kogushi-Nishi H; Jinnin M; Kobayashi Y; Muchemwa FC; Hirano A; Makino T; Fukushima S; Masuguchi S; Ishihara T; Inoue Y; Ihn H
    Clin Exp Dermatol; 2013 Dec; 38(8):890-6. PubMed ID: 24252081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
    Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
    Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.
    Fogarty MP; Downer EJ; Campbell V
    Biochem J; 2003 May; 371(Pt 3):789-98. PubMed ID: 12534344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance.
    Tuncman G; Hirosumi J; Solinas G; Chang L; Karin M; Hotamisligil GS
    Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10741-6. PubMed ID: 16818881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
    Gancz D; Donin N; Fishelson Z
    Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JNK1 is not essential for TNF-mediated joint disease.
    Köller M; Hayer S; Redlich K; Ricci R; David JP; Steiner G; Smolen JS; Wagner EF; Schett G
    Arthritis Res Ther; 2005; 7(1):R166-73. PubMed ID: 15642137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licochalcone A, a natural inhibitor of c-Jun N-terminal kinase 1.
    Yao K; Chen H; Lee MH; Li H; Ma W; Peng C; Song NR; Lee KW; Bode AM; Dong Z; Dong Z
    Cancer Prev Res (Phila); 2014 Jan; 7(1):139-49. PubMed ID: 24253317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
    Schattenberg JM; Singh R; Wang Y; Lefkowitch JH; Rigoli RM; Scherer PE; Czaja MJ
    Hepatology; 2006 Jan; 43(1):163-72. PubMed ID: 16374858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.